Skip to content

Dietary Approach to Stop Hypertension With Sodium (Na) Reduction for Chinese Canadians

Dietary Approach to Stop Hypertension With Sodium (Na) Reduction for Chinese Canadians

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02579746
Acronym
DASHNa-CC
Enrollment
60
Registered
2015-10-20
Start date
2014-08-31
Completion date
2015-08-31
Last updated
2015-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

hypertension, immigrant, dietary intervention, lifestyle modification

Brief summary

The study examined the feasibility of the Dietary Approach to Stop Hypertension with Sodium (Na) Reduction for Chinese Canadian (DASHNa-CC) intervention and its potential effects on blood pressure, health-related quality of life, and health service utilization. Half of participants received usual care while the other half received the DASHNa-CC intervention.

Detailed description

Hypertension has been identified as the most important risk factor for cardiovascular diseases and accounts for a large proportion of stroke, myocardial infarction and heart failure in the Chinese population. While unhealthy diet has been identified as a modifiable risk factor for hypertension, there is a lack of culturally sensitive dietary intervention targeting Chinese Canadians. The 8-week DASHNa-CC intervention incorporated Dietary Approach to Stop Hypertension (DASH) diet, sodium reduction with the food therapy of Traditional Chinese Medicine, and included an intervention manual, two sessions of classroom instruction delivered in Mandarin, and a 20-minute telephone follow-up.

Interventions

BEHAVIORALDASHNa-CC

The 8-week DASHNa-CC intervention incorporated Dietary Approach to Stop Hypertension (DASH) diet, sodium reduction with the food therapy of Traditional Chinese Medicine, and included an intervention manual, two sessions of classroom instruction delivered in Mandarin, and a 20-minute telephone follow-up.

BEHAVIORALusual care

education booklet, encouragement of physician visit, use of public health resources if needed

Sponsors

University of Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* were at least 45 years old; * had a systolic blood pressure 140 to 159 mmHg, or a diastolic blood pressure 90 to 99 mmHg, based on pre-intervention baseline assessment; * were able to understand (listen) and speak in Mandarin, read and write in Chinese; and * had access to a telephone.

Exclusion criteria

* used antihypertensive medications or other medications that raise or lower blood pressure during the previous three months; * used TCM or professional TCM counselling to decrease blood pressure during the previous three months; * used insulin or oral hypoglycemic agents during the previous three months; * had a history of a cardiovascular event (stroke, myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass surgery, or other arteriosclerotic cardiovascular disease related therapeutic procedure) during the previous three months; * had a history of congestive heart failure; * had a cancer diagnosis or treatment during the past two years; * had special dietary requirements; * were pregnant, breast feeding, or planned for pregnancy prior to the anticipated end of study; * were a household member of another DASHNa-CC participant; or * planned to leave the area prior to the anticipated end of study.

Design outcomes

Primary

MeasureTime frameDescription
blood pressure8 weeks post randomizationsystolic and diastolic blood pressure

Secondary

MeasureTime frameDescription
health related quality of life8 weeks post randomizationused SF-36v2

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026